MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$118,520K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from issuance of exchan...
Proceeds from term loans
Draws on revolving credit facili...
Others
Negative Cash Flow Breakdown
Principal payments on debt and t...
Investments in life science fina...
Repayments on revolving credit f...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income
43,852
32,809
31,841
29,305
Depreciation and amortization
18,799
18,584
18,538
18,639
Impairment loss on real estate
0
0
0
0
Loss (gain) on exchange of exchangeable senior notes
-
-
0
-
Loss (gain) on sale of real estate, net
11,847
422
-326
0
Paid-in-kind dividends and interest income on life science investments
1,546
1,002
826
-
Stock-based compensation
2,826
2,584
2,698
2,684
Amortization of discounts on investments
-
-
0
0
Amortization of debt discount and issuance costs
1,211
576
568
485
Other non-cash adjustments
1,547
300
292
-12
Other assets, net
-3,442
527
-1,550
6,555
Accounts payable, accrued expenses and other liabilities
-4,923
3,976
-3,607
1,472
Rent received in advance and tenant security deposits
-5,350
-247
-889
-451
Net cash provided by (used in) operating activities
44,917
56,031
49,907
45,591
Investments in real estate
0
0
0
0
Investments in life science financial instruments
120,000
-
45,016
105,235
Proceeds from sale of real estate assets
42,584
2,608
489
0
Funding of draws for improvements and construction
642
2,949
2,456
4,429
Funding of construction loan and other investments
-
-
0
-
Purchases of short-term investments
0
0
0
0
Maturities of short-term investments
0
0
5,258
0
Net cash provided by (used in) investing activities
-78,058
-341
-41,725
-109,664
Issuance of common stock, net of issuance costs
34,750
9,281
0
0
Repurchase of common stock
88,969
0
0
0
Issuance of preferred stock, net of issuance costs
20,914
60,301
5,037
5,900
Proceeds from issuance of exchangeable notes
402,500
-
-
-
Proceeds from term loans
148,660
-
-
-
Principal payments on debt and term loans
311,274
0
0
8,697
Draws on revolving credit facilities
120,000
5,000
105,000
50,000
Repayments on revolving credit facilities
102,500
32,500
52,500
-
Payment of deferred financing costs
15,320
-
0
0
Dividends paid to common stockholders
54,446
53,777
53,776
53,783
Dividends paid to preferred stockholders
2,654
1,136
1,017
878
Taxes paid related to net share settlement of equity awards
0
1,339
0
161
Net cash provided by (used in) financing activities
151,661
-14,170
2,744
1,078
Net increase (decrease) in cash, cash equivalents and restricted cash
118,520
41,520
10,926
-62,995
Cash and cash equivalents, beginning of period
89,117
47,597
36,671
146,245
Cash, cash equivalents and restricted cash, end of period
207,637
89,117
47,597
36,671
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from issuance of
exchangeable notes
$402,500K
Net income
$43,852K
(-23.20%↓ Y/Y)
Depreciation and
amortization
$18,799K
(-49.04%↓ Y/Y)
Proceeds from term loans
$148,660K
Draws on revolving
credit facilities
$120,000K
Issuance of common stock,
net of issuance...
$34,750K
Issuance of preferred
stock, net of issuance...
$20,914K
(58.31%↑ Y/Y)
Other assets, net
-$3,442K
(7.45%↑ Y/Y)
Stock-based compensation
$2,826K
(-40.51%↓ Y/Y)
Amortization of debt discount
and issuance costs
$1,211K
(28.01%↑ Y/Y)
Net cash provided by
(used in) financing...
$151,661K
(220.02%↑ Y/Y)
Net cash provided by
(used in) operating...
$44,917K
(-56.26%↓ Y/Y)
Canceled cashflow
$575,163K
Canceled cashflow
$25,213K
Net increase
(decrease) in cash, cash...
$118,520K
(354.45%↑ Y/Y)
Canceled cashflow
$78,058K
Principal payments on debt
and term loans
$311,274K
Repayments on revolving
credit facilities
$102,500K
Repurchase of common stock
$88,969K
(342.46%↑ Y/Y)
Dividends paid to common
stockholders
$54,446K
(-49.92%↓ Y/Y)
Payment of deferred
financing costs
$15,320K
Dividends paid to
preferred stockholders
$2,654K
(97.32%↑ Y/Y)
Proceeds from sale of real
estate assets
$42,584K
(2333.37%↑ Y/Y)
Loss (gain) on sale of
real estate, net
$11,847K
Rent received in
advance and tenant...
-$5,350K
(3.24%↑ Y/Y)
Accounts payable,
accrued expenses and...
-$4,923K
(-484.31%↓ Y/Y)
Other non-cash
adjustments
$1,547K
(31040.00%↑ Y/Y)
Paid-in-kind dividends and
interest income on life...
$1,546K
Net cash provided by
(used in) investing...
-$78,058K
(-240.69%↓ Y/Y)
Canceled cashflow
$42,584K
Investments in life science
financial instruments
$120,000K
Funding of draws for
improvements and...
$642K
(-96.12%↓ Y/Y)
Buy us a coffee
INNOVATIVE INDUSTRIAL PROPERTIES INC (IIPR)
INNOVATIVE INDUSTRIAL PROPERTIES INC (IIPR)